tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Lantern Pharma’s Earnings Call: Progress and Prospects
PremiumCompany AnnouncementsLantern Pharma’s Earnings Call: Progress and Prospects
2M ago
Lantern Pharma Reports Q1 2025 Financial Results
Premium
Company Announcements
Lantern Pharma Reports Q1 2025 Financial Results
2M ago
Lantern Pharma secures FDA clearance for planned Phase 1b/2 trial of LP-184
Premium
The Fly
Lantern Pharma secures FDA clearance for planned Phase 1b/2 trial of LP-184
2M ago
Lantern Pharma Advances AI-Driven Oncology Pipeline
PremiumCompany AnnouncementsLantern Pharma Advances AI-Driven Oncology Pipeline
4M ago
Lantern Pharma Reports Q4 2024 Financial Results and AI Progress
Premium
Company Announcements
Lantern Pharma Reports Q4 2024 Financial Results and AI Progress
4M ago
Lantern Pharma reports Q4 EPS (54c) vs (39c) last year
Premium
The Fly
Lantern Pharma reports Q4 EPS (54c) vs (39c) last year
4M ago
Lantern Pharma granted fast track designation for LP-184
PremiumThe FlyLantern Pharma granted fast track designation for LP-184
8M ago
Lantern Pharma doses first patient in LP-300 trial expansion cohort
Premium
The Fly
Lantern Pharma doses first patient in LP-300 trial expansion cohort
8M ago
Lantern Pharma Discusses Q3 Financial Results Webinar
Premium
Company Announcements
Lantern Pharma Discusses Q3 Financial Results Webinar
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100